Trial Profile
Clinical Practice of Thromboprophylaxis with Treatment of Apixaban in Chinese Patients after Total Knee/ Total Hip Replacement: a Multi-Center Prospective Registry Study
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 12 Feb 2018
Price :
$35
*
At a glance
- Drugs Apixaban (Primary)
- Indications Thromboembolism
- Focus Therapeutic Use
- 12 Feb 2018 New trial record